Ann: Quarterly Activities and Cashflow Reports March 2018, page-20

First 20 Last

Share
Profile

Follow
shakespeare

1,875 Posts.

12

02/05/18

07:56

Post #: 32815984
Share

Originally posted by Smite ↑

I don't know why we focus on minutiae of details like reagents and capacity of pilot. They dont have to tell you and probably never will.

Think outcomes guys...these are the things I think that matter at this stage are:
1. Are they working on met work, do they have it locked down? (Not yet its a 'work in progress')
2. Do we have a means of rapidly testing out met work (fail fast to develop a method)
3. Do we have samples to test to indicate coverage of target areas (yes)
4. Do we have the right set of experts and experience looking at this (?)
4. Can we fund this quarter (yes)
5. Where will funds come from for next quarter ( there are options, trial mining or CR) i suspect they are awaiting ema results before CR to reduce the number of new shares.

Later on, I would expect that we start to see economic outputs when a met process is locked down. Such as.... Is the approach economical or not, with costs per ounce.

I know we all like to geek out on reagents and stuff like that, but as investors, you need to put your business hats on and care about outcomes rather than double checking their work.

As an example of what youre doing, its like asking an airline the exact means by which they come to decide the routes they fly. They will never tell you. What they will is: Is the new route economical or not, what does it enable for the business, & how does it perform (in operation)

Thx, smite.

Expand

thanks for that smite
your last example was more apt than you think in that
the problem for investors is that its not qantas here
a level of trust is required in the company to
get the art right and the mystery and uncertainty is in here.

BBX Price at posting: 20.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

AUN

Cyclone signs MOU with Vale for development of Iron Bear play

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

HotCopper Highlights: Your most watched stocks for Week 46, 2024

EDE

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

AN1

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

ME1

Banshee's historic trenches prove rich in antimony and gold for GDM

LYN

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

There are more pages in this discussion • 16 more messages in this thread...

First 20 Last

Add BBX (ASX) to my watchlist

Ann: Quarterly Activities and Cashflow Reports March 2018, page-20

Top Stories

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Cyclone signs MOU with Vale for development of Iron Bear play

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

HotCopper Highlights: Your most watched stocks for Week 46, 2024

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Banshee's historic trenches prove rich in antimony and gold for GDM

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain